BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17089135)

  • 1. Involvement of hypocretin neurons in multiple system atrophy.
    Benarroch EE; Schmeichel AM; Sandroni P; Low PA; Parisi JE
    Acta Neuropathol; 2007 Jan; 113(1):75-80. PubMed ID: 17089135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy.
    Benarroch EE; Schmeichel AM; Sandroni P; Low PA; Parisi JE
    Brain; 2006 Oct; 129(Pt 10):2688-96. PubMed ID: 16670175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy.
    Benarroch EE; Schmeichel AM; Low PA; Parisi JE
    Brain; 2007 Feb; 130(Pt 2):469-75. PubMed ID: 17235127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum.
    Kohlmeier KA; Inoue T; Leonard CS
    J Neurophysiol; 2004 Jul; 92(1):221-35. PubMed ID: 14999052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death.
    Tada M; Kakita A; Toyoshima Y; Onodera O; Ozawa T; Morita T; Nishizawa M; Takahashi H
    Brain; 2009 Jul; 132(Pt 7):1810-9. PubMed ID: 19429902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy.
    Schmeichel AM; Buchhalter LC; Low PA; Parisi JE; Boeve BW; Sandroni P; Benarroch EE
    Neurology; 2008 Jan; 70(5):368-73. PubMed ID: 18227417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rostral raphe involvement in Lewy body dementia and multiple system atrophy.
    Benarroch EE; Schmeichel AM; Sandroni P; Parisi JE; Low PA
    Acta Neuropathol; 2007 Sep; 114(3):213-20. PubMed ID: 17639427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between CSF hypocretin levels and hypocretin neuronal loss.
    Gerashchenko D; Murillo-Rodriguez E; Lin L; Xu M; Hallett L; Nishino S; Mignot E; Shiromani PJ
    Exp Neurol; 2003 Dec; 184(2):1010-6. PubMed ID: 14769395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF hypocretin-1 levels are normal in multiple-system atrophy.
    Abdo WF; Bloem BR; Kremer HP; Lammers GJ; Verbeek MM; Overeem S
    Parkinsonism Relat Disord; 2008; 14(4):342-4. PubMed ID: 17977056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of medullary serotonergic groups in multiple system atrophy.
    Benarroch EE; Schmeichel AM; Low PA; Parisi JE
    Ann Neurol; 2004 Mar; 55(3):418-22. PubMed ID: 14991820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
    Borgland SL; Storm E; Bonci A
    Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system atrophy.
    Benarroch EE; Schmeichel AM; Low PA; Parisi JE
    Brain; 2003 Oct; 126(Pt 10):2183-90. PubMed ID: 12902309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitatory action of hypocretin/orexin on neurons of the central medial amygdala.
    Bisetti A; Cvetkovic V; Serafin M; Bayer L; Machard D; Jones BE; Mühlethaler M
    Neuroscience; 2006 Nov; 142(4):999-1004. PubMed ID: 16996221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease.
    Benarroch EE; Schmeichel AM; Sandroni P; Low PA; Parisi JE
    Neurology; 2006 Feb; 66(3):378-83. PubMed ID: 16476936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Loss of catecholaminergic neuron in the hypothalamus of multiple system atrophy].
    Tsai A; Maehara K; Iizuka R
    Rinsho Shinkeigaku; 1992 Feb; 32(2):125-30. PubMed ID: 1351801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocretin (orexin) loss in Parkinson's disease.
    Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
    Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
    Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure.
    Benarroch EE; Smithson IL; Low PA; Parisi JE
    Ann Neurol; 1998 Feb; 43(2):156-63. PubMed ID: 9485056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression.
    Allard JS; Tizabi Y; Shaffery JP; Trouth CO; Manaye K
    Neuropeptides; 2004 Oct; 38(5):311-5. PubMed ID: 15464197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-sleep effects of hypocretin/orexin.
    Samson WK; Taylor MM; Ferguson AV
    Sleep Med Rev; 2005 Aug; 9(4):243-52. PubMed ID: 16036174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.